NR ADRL
AU Dzik,S.; Aubuchon,J.; Jeffries,L.; Kleinman,S.; Manno,C.; Murphy,M.F.; Popovsky,M.A.; Sayers,M.; Silberstein,L.E.; Slichter,S.J.; Vamvakas,E.C.
TI Leukocyte reduction of blood components: public policy and new technology.
QU Transfusion Medicine Reviews 2000 Jan; 14(1): 34-52
PT journal article; review; review, tutorial
ZR 104
MH Adjuvants, Immunologic; Blood Component Removal/adverse effects/economics/*standards; Blood Component Transfusion/adverse effects/economics/*standards; Costs and Cost Analysis; Creutzfeldt-Jakob Syndrome/prevention & control; Europe; Human; Immune System/physiopathology; Leukocytes/*immunology; Public Policy; United States
AD Blood Transfusion Service, Massachusetts General Hospital, Boston 02114, USA
SP englisch
PO USA